FDA warns of fractures with prolonged usage of heartburn drugs
May 26th, 2010 - 7:51 pm ICT by Aishwarya BhattWashington DC, May 26 (THAINDIAN NEWS) The Food and Drugs Administration said that heartburn drugs like Prilosec and Nexium could be the cause of bone fractures during prolonged use. The FDA has therefore warned doctors and patients against using the drug for more than a year. The FDA issued the warning on Tuesday, and said the association between the drug and bone fractures was not immediately known, but the agency said more studies have tracked increased risk of bone fractures.
The FDA also added that the studies showed increased risk of hip, spine and wrist fractures. The drugs belong to a group of drugs called ‘proton pump inhibitors’ and they are widely used in the United States. Last year, the total sales of the drug were $13.6 billion. This whooping figure of $13.6 billion made the proton pump inhibitors the third best selling prescription drugs in the United States. The drugs have widespread usage, as they are available over-the-counter. Some of the common prescription brands are Prevacid from Takeda and Nexium from AstraZeneca. The over-the-counter forms available include Procter & Gamble’s Prilosec.
The Food and Drug Administration has issued a new directive to the drug manufacturers to put warning of the potential risk of the drug on the labels.
- Heartburn Drugs Can Cause Fractures - May 26, 2010
- Heartburn Drugs May Cause Fractures, Says FDA - May 26, 2010
- Heartburn drugs increase risk of hip fractures - Jun 05, 2009
- Bristol Myers Get Approval For Their Diabetes Drug - Nov 07, 2010
- Drug Maker, AstraZeneca, To Reimburse $520 Million - Apr 28, 2010
- Heartburn pills 'can raise osteoporosis risk' - May 29, 2010
- Heartburn pills may cause osteoporosis - May 30, 2010
- Asthama Drugs Get New FDA Regulations - Feb 19, 2010
- FDA Orders Limitations On Vicodin's Key Ingredient Acetaminophen - Jan 14, 2011
- Common heartburn drugs may reduce anti-clotting medications' benefits - May 07, 2009
- Indigestion drugs can up brittle bone risk - Aug 17, 2008
- Drug, cosmetics firms back plan to end animal testing - Nov 28, 2010
- New research to identify antibiotics that may help fight TB - Mar 12, 2011
- Drug counters bone-damaging effects of breast cancer medication - Oct 10, 2011
- Drug Maker AstraZeneca Slapped With $520 Million Fine - Apr 28, 2010
Tags: astrazeneca, bone fractures, doctors, drug manufacturers, drugs administration, fda, food and drug, food and drug administration, labels, nexium, prescription drugs, prevacid, prilosec, procter gamble, proton pump inhibitors, risk, spine, takeda, washington dc
